Zevra Therapeutics Inventory

Zevra Therapeutics (ZVRA) currently reports a inventory of $2.3M as of March 2026. That compares with $2.6M in the prior-year period — down 9.7% year over year. Use the charts on this page to explore Zevra Therapeutics's inventory history and peer comparisons.

Zevra Therapeutics's inventory decreased from $2.6M to $2.3M — a 9.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zevra Therapeutics reported $2.3M in inventory as of March 2026. That compares with $2.6M in the prior-year period — down 9.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $2.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zevra Therapeutics, and consider following ZVRA for alerts when major investors trade the stock.

Zevra Therapeutics is classified in the Healthcare sector. On inventory, it currently shows $2.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZVRA with unrelated industries.